Katja Kanninen Selected Research

proteoglycan-degrading metalloendopeptidases

1/2016	ADAMTS-4 promotes neurodegeneration in a mouse model of amyotrophic lateral sclerosis.
10/2013	ADAMTS proteoglycanases in the physiological and pathological central nervous system.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Katja Kanninen Research Topics

Disease

8	Alzheimer Disease (Alzheimer's Disease) 01/2011 - 09/2004
7	Inflammation (Inflammations) 08/2016 - 06/2006
4	Spinal Cord Injuries (Spinal Cord Injury) 01/2016 - 01/2007
4	Gliosis 02/2015 - 06/2006
2	Ischemia 08/2016 - 04/2007
2	Wounds and Injuries (Trauma) 02/2015 - 10/2013
2	Demyelinating Diseases (Demyelinating Disease) 02/2015 - 03/2014
2	Contusions 02/2015 - 03/2014
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 06/2011 - 01/2007
2	Brain Ischemia (Cerebral Ischemia) 04/2007 - 01/2007
1	Epilepsy (Aura) 10/2017
1	Post-Traumatic Epilepsy (Epilepsy, Post Traumatic) 10/2017
1	Central Nervous System Diseases (CNS Diseases) 01/2016
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 02/2015
1	Neuroinflammatory Diseases 04/2014
1	Atrophy 03/2014
1	Stroke (Strokes) 10/2013
1	Neurodegenerative Diseases (Neurodegenerative Disease) 06/2011
1	Primary Immunodeficiency Diseases 12/2010
1	Hypoxia (Hypoxemia) 04/2007
1	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 01/2007
1	Arthritis (Polyarthritis) 01/2007

Drug/Important Bio-Agent (IBA)

3	Transcription Factors (Transcription Factor)IBA 08/2016 - 01/2007
3	NF-kappa B (NF-kB)IBA 08/2016 - 01/2007
3	Amyloid beta-PeptidesIBA 09/2009 - 06/2006
2	proteoglycan-degrading metalloendopeptidasesIBA 01/2016 - 10/2013
2	Proteins (Proteins, Gene)FDA Link 01/2011 - 09/2004
2	Peptides (Polypeptides)IBA 12/2010 - 06/2006
2	Amyloid (Amyloid Fibrils)IBA 12/2010 - 09/2009
2	AntioxidantsIBA 04/2007 - 01/2007
2	pyrrolidine dithiocarbamic acidIBA 04/2007 - 01/2007
2	prolinedithiocarbamate (PDTC)IBA 04/2007 - 01/2007
1	Pentylenetetrazole (Metrazol)IBA 10/2017
1	atipamezoleIBA 10/2017
1	Interleukin-33IBA 02/2015
1	Nerve Growth Factors (Neurotrophins)IBA 03/2014
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 06/2011
1	pegfilgrastim (Neulasta)FDA Link 06/2011
1	Glycogen Synthase (Synthase I)IBA 01/2011
1	AntibodiesIBA 12/2010
1	Intravenous Immunoglobulins (IVIG)FDA Link 12/2010
1	A 7 (A-7)IBA 04/2007
1	Glycogen Synthase KinasesIBA 04/2007
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 04/2007
1	Glycogen Synthase Kinase 3 betaIBA 04/2007
1	Superoxide Dismutase-1IBA 06/2006
1	Pro-Q aerosol foamIBA 09/2004
1	Glycoproteins (Glycoprotein)IBA 09/2004
1	ProteomeIBA 09/2004

Therapy/Procedure

1	Aftercare (After-Treatment) 10/2017
1	Therapeutics 01/2011